Onconic Therapeutics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	610,735	869,777	176,537	-	-	-
Market Cap Growth	163.08%	392.69%	-	-	-	-
Enterprise Value	553,545	816,363	152,373	-	-	-
Last Close Price	13450.00	19550.00	4085.00	-	-	-
PE Ratio	30.50	55.11	-	-	-	-
PS Ratio	9.09	16.29	11.90	-	-	-
PB Ratio	7.68	12.07	3.15	-	-	-
P/TBV Ratio	7.68	12.07	3.15	-	-	-
P/FCF Ratio	46.11	78.41	-	-	-	-
P/OCF Ratio	44.95	76.33	-	-	-	-
EV/Sales Ratio	8.24	15.29	10.27	-	-	-
EV/EBITDA Ratio	34.22	62.09	-	-	-	-
EV/EBIT Ratio	35.42	64.69	-	-	-	-
EV/FCF Ratio	41.79	73.60	-	-	-	-
Debt / Equity Ratio	0.00	0.00	0.01	-0.06	0.00	-0.02
Debt / EBITDA Ratio	0.01	0.01	-	0.13	-	-
Debt / FCF Ratio	0.01	0.01	-	0.12	-	-
Net Debt / Equity Ratio	-0.72	-0.73	-0.76	5.05	1.24	2.34
Net Debt / EBITDA Ratio	-3.54	-4.00	9.82	-11.05	1.85	2.25
Net Debt / FCF Ratio	-4.32	-4.74	5.35	-9.97	1.56	2.11
Asset Turnover	0.90	0.78	0.30	0.62	0.00	-
Quick Ratio	9.42	17.48	10.61	0.71	1.06	36.08
Current Ratio	9.48	17.62	10.94	0.71	1.06	36.10
Return on Equity (ROE)	29.48%	24.65%	-32.29%	-	-	-
Return on Assets (ROA)	13.01%	11.55%	-6.09%	4.07%	-36.85%	-
Return on Capital Employed (ROCE)	19.60%	17.50%	-8.50%	-39.40%	-343.70%	-44.10%
Earnings Yield	3.33%	1.81%	-4.58%	-	-	-
FCF Yield	2.17%	1.27%	-4.52%	-	-	-
Buyback Yield / Dilution	-6.36%	-38.72%	-41.46%	0.00%	-0.94%	-